DE69215035D1 - Zusammensetzung, die Rhodacyanine-Farbstoffen enthält, zur Behandlung von Krebs - Google Patents

Zusammensetzung, die Rhodacyanine-Farbstoffen enthält, zur Behandlung von Krebs

Info

Publication number
DE69215035D1
DE69215035D1 DE69215035T DE69215035T DE69215035D1 DE 69215035 D1 DE69215035 D1 DE 69215035D1 DE 69215035 T DE69215035 T DE 69215035T DE 69215035 T DE69215035 T DE 69215035T DE 69215035 D1 DE69215035 D1 DE 69215035D1
Authority
DE
Germany
Prior art keywords
different
same
group
chem
alkyl group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69215035T
Other languages
English (en)
Other versions
DE69215035T2 (de
Inventor
Lan Bo Cen
Tadao Shishido
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujifilm Holdings Corp
Dana Farber Cancer Institute Inc
Original Assignee
Fuji Photo Film Co Ltd
Dana Farber Cancer Institute Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fuji Photo Film Co Ltd, Dana Farber Cancer Institute Inc filed Critical Fuji Photo Film Co Ltd
Application granted granted Critical
Publication of DE69215035D1 publication Critical patent/DE69215035D1/de
Publication of DE69215035T2 publication Critical patent/DE69215035T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Paper (AREA)
  • Gas Separation By Absorption (AREA)
  • Luminescent Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DE69215035T 1991-08-13 1992-08-13 Zusammensetzung, die Rhodacyanine-Farbstoffen enthält, zur Behandlung von Krebs Expired - Lifetime DE69215035T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US74413091A 1991-08-13 1991-08-13

Publications (2)

Publication Number Publication Date
DE69215035D1 true DE69215035D1 (de) 1996-12-12
DE69215035T2 DE69215035T2 (de) 1997-04-03

Family

ID=24991548

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69215035T Expired - Lifetime DE69215035T2 (de) 1991-08-13 1992-08-13 Zusammensetzung, die Rhodacyanine-Farbstoffen enthält, zur Behandlung von Krebs

Country Status (15)

Country Link
US (1) US5360803A (de)
EP (1) EP0527494B1 (de)
JP (1) JP2567328B2 (de)
CN (1) CN1071834A (de)
AT (1) ATE144897T1 (de)
AU (1) AU649865B2 (de)
CA (1) CA2075750C (de)
DE (1) DE69215035T2 (de)
DK (1) DK0527494T3 (de)
ES (1) ES2096685T3 (de)
FI (1) FI923604A (de)
GR (1) GR3021865T3 (de)
HU (1) HUT64224A (de)
NO (1) NO923126L (de)
ZA (1) ZA926004B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996003393A1 (en) * 1994-07-21 1996-02-08 Fuji Photo Film Co., Ltd. Water-soluble methine compound and pharmaceutical composition for treatment of cancer comprising the same
US5599825A (en) * 1994-07-21 1997-02-04 Fuji Photo Film Co., Ltd. Water-soluble methine compound and pharmaceutical composition for treatment of cancer comprising the same
JPH0921985A (ja) * 1995-07-07 1997-01-21 Nec Corp マッハツェンダー変調器及びその製造方法
ATE253908T1 (de) 1995-08-16 2003-11-15 Huntington Medical Res Inst Rhodamin 123 zusammensetzungen für behandlung von prostatakrebs
US7329741B2 (en) * 1996-06-05 2008-02-12 Chiron Corporation Polynucleotides that hybridize to DP-75 and their use
DE19908535A1 (de) 1999-02-26 2000-08-31 Aventis Pharma Gmbh Verwendung von polycyclischen Thiazol-Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas
DE10032290C2 (de) * 2000-07-03 2002-05-08 Roche Diagnostics Gmbh Adsorptionsmittelhaltige Kontrollflüssigkeit
JP2003034641A (ja) * 2001-07-19 2003-02-07 Japan Science & Technology Corp ロダシアニン系色素化合物を含有する抗マラリア剤
TW200408407A (en) * 2001-11-30 2004-06-01 Dana Farber Cancer Inst Inc Methods and compositions for modulating the immune system and uses thereof
JP2004331545A (ja) * 2003-05-06 2004-11-25 Japan Science & Technology Agency 抗リーシュマニア剤
FR2874319B1 (fr) * 2004-08-19 2008-05-16 Oreal Composition pour la teinture des fibres keratiniques comprenant un colorant direct methinique contenant un motif benzoselenazolium
JP4553355B2 (ja) 2004-10-04 2010-09-29 富士フイルム株式会社 トリパノソーマ原虫寄生感染症の予防又は治療用医薬組成物
US20060099712A1 (en) * 2004-11-08 2006-05-11 Eastman Kodak Company Correlation of anti-cancer activity of dyes with redox potentials
US8293716B2 (en) 2005-05-26 2012-10-23 Ramot At Tel Aviv University Ltd. Method of treating cancer by modulation of mortalin
GB0603455D0 (en) * 2006-02-21 2006-04-05 Cancer Rec Tech Ltd Therapeutic compounds
JP2010505750A (ja) * 2006-09-14 2010-02-25 ラモット・アット・テル・アビブ・ユニバーシテイ・リミテッド 腫瘍疾患治療のための混合治療
US8470793B2 (en) 2007-09-25 2013-06-25 Ramot At Tel-Aviv University Ltd. Down-regulation of mortalin by siRNA
US9642843B2 (en) * 2013-02-27 2017-05-09 The Regents Of The University Of Michigan Pharmaceutical compounds and use of same in cancer and tauopathies
CN104177312B (zh) * 2013-05-27 2018-02-13 黄英武 一种含硒化合物及其医药用途
US10221171B2 (en) 2015-01-09 2019-03-05 The Regents Of The University Of California Oxathiazole thiazolium Hsp 70 inhibitors

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2536986A (en) * 1951-01-02 Thiazolone cyan
GB487051A (en) * 1936-11-14 1938-06-14 John David Kendall Improvements in or relating to dyestuffs
GB489335A (en) * 1937-01-22 1938-07-22 Douglas James Fry Improvements in or relating to the manufacture and use of dyestuffs suitable for sensitising photographic emulsions
US2454629A (en) * 1940-01-27 1948-11-23 Eastman Kodak Co Polymethine dyes
BE485784A (de) * 1947-11-18
BE571507A (de) * 1957-09-30
US3454629A (en) * 1962-08-17 1969-07-08 Ciba Geigy Corp Novel phenylalanine compounds
JPS53144727A (en) * 1977-05-24 1978-12-16 Konishiroku Photo Ind Co Ltd Photographic product
DE2919447A1 (de) * 1978-05-17 1979-11-22 Takeda Chemical Industries Ltd Tumorhemmendes mittel
JPS5569513A (en) * 1978-11-20 1980-05-26 Takeda Chem Ind Ltd Anti-tumor agent
JPS55100318A (en) * 1979-01-26 1980-07-31 Takeda Chem Ind Ltd Antitumorigenic agent
JPS54151133A (en) * 1978-05-17 1979-11-28 Takeda Chem Ind Ltd Antitumorigenic agent
AU1144688A (en) * 1987-03-17 1988-09-15 Dana-Farber Cancer Institute, Inc. A pharmaceutical composition comprising cyanine dye
JPH0652210B2 (ja) * 1987-08-26 1994-07-06 宣行 杉村 アキユムレ−タのガス封入圧力測定方法
JP2824917B2 (ja) * 1989-08-30 1998-11-18 株式会社林原生物化学研究所 抗腫瘍剤

Also Published As

Publication number Publication date
GR3021865T3 (en) 1997-03-31
DE69215035T2 (de) 1997-04-03
CA2075750A1 (en) 1993-02-14
AU2097492A (en) 1993-02-25
ZA926004B (en) 1993-03-02
HU9202609D0 (en) 1992-10-28
FI923604A (fi) 1993-02-14
FI923604A0 (fi) 1992-08-12
JP2567328B2 (ja) 1996-12-25
EP0527494A1 (de) 1993-02-17
ATE144897T1 (de) 1996-11-15
CN1071834A (zh) 1993-05-12
EP0527494B1 (de) 1996-11-06
CA2075750C (en) 1998-02-24
JPH06172330A (ja) 1994-06-21
NO923126L (no) 1993-02-15
US5360803A (en) 1994-11-01
ES2096685T3 (es) 1997-03-16
AU649865B2 (en) 1994-06-02
NO923126D0 (no) 1992-08-11
HUT64224A (en) 1993-12-28
DK0527494T3 (da) 1996-11-25

Similar Documents

Publication Publication Date Title
DE69215035D1 (de) Zusammensetzung, die Rhodacyanine-Farbstoffen enthält, zur Behandlung von Krebs
DE69232336D1 (de) Stickstoff enthaltende hydrocyclische verbindungen
ATE142494T1 (de) 2-arylthiazolderivat sowie dieses enthaltendes arzneimittel
HU9603433D0 (en) Novel 4-6-diaryl-pyrimidine-derivatives and salts thereof
ATE224T1 (de) 1,2-dihydro-chinolin-2-on-derivate, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel.
NO306992B1 (no) Quinolinderivater, farmasoeytiske preparater inneholdende forbindelsene og anvendelsen av forbindelsene
JO1617B1 (en) Modern 2-amino-tetraline-8 compounds
GB1424450A (en) Isoindoline intermediates
ATE32894T1 (de) Thiomethylpyridin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
GB1223501A (en) Novel halogenated salicylaldehyde schiff's bases
DE3267188D1 (en) Hydroxybenzylamino-aryl compounds, process for preparing and pharmaceutical compositions containing the same
DE69201848D1 (de) Verfahren zum Härten von Gelatine.
GB1064293A (en) Substituted 2-pyrrylketones
GB1398687A (en) Substituted oxazolidinones and pharmaceutical uses thereof
TH17758A (th) สารเคมี
ATE44741T1 (de) 2-(n-substituierte guanidino)-4heteroarylthiazole als mittel gegen geschwuere.
TH8849EX (th) 8-ซับสทิทิวเทด-2-อะมิโนเททระลีนชนิดใหม่
TH5413A (th) อนุพันธ์โครแมนชนิดใหม่
BE900322A (fr) Nouveaux derives du 1,2,4-triazole.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
R071 Expiry of right

Ref document number: 527494

Country of ref document: EP